ARCHIVES

Abraxane-Gemcitabine Combination Extends Overall Survival in Phase III Trial

This article is from The Cancer Letter archive.

Vol. 37 No. 1 | January 31, 2014

Download PDF Visit The Full Archive

Related Articles

FDA, Clinical Investigators Head Or Showdown Over Demand To See Individual Patient Records

April 18, 1980

NCI Research Plan Proposes Spending $5 Billion In FY2002.

November 3, 2000

DCBDC Bard Approves Expansion Of SPORE Program To GY Cancers; Okays Two other RFAs

December 4, 1992

In Phase II Study, Vaccine IMA910 Stimulated Immune Response

February 24, 2012

IOM Selects Advisors To Defense Department

February 5, 1993

In Brief: Hutchinson Begins Prostate Cancer Study; Meyer Named GWU Medical Dean; Nurses Win VA Posts

April 9, 1993